MARCHESI, Irene
 Distribuzione geografica
Continente #
NA - Nord America 496
EU - Europa 197
AS - Asia 133
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 832
Nazione #
US - Stati Uniti d'America 492
UA - Ucraina 77
CN - Cina 67
IT - Italia 51
SG - Singapore 41
DE - Germania 33
TR - Turchia 15
FI - Finlandia 10
BE - Belgio 8
CA - Canada 4
KR - Corea 4
CZ - Repubblica Ceca 3
EU - Europa 3
GB - Regno Unito 3
AU - Australia 2
ES - Italia 2
FR - Francia 2
IN - India 2
IR - Iran 2
NL - Olanda 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
IQ - Iraq 1
PT - Portogallo 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 832
Città #
Chandler 167
Jacksonville 49
Princeton 40
New York 36
Sassari 28
Singapore 28
Nanjing 24
Izmir 14
Ann Arbor 13
Dearborn 12
Wilmington 11
Beijing 9
Brussels 8
Cagliari 5
Nanchang 5
Norwalk 5
Shenyang 5
Seoul 4
Woodbridge 4
Boardman 3
Mountain View 3
Munich 3
Nuoro 3
Toronto 3
Ardabil 2
Ashburn 2
Brno 2
Changsha 2
Hebei 2
Helsinki 2
Jiaxing 2
Lansdale 2
Madrid 2
Ningbo 2
Philadelphia 2
Sandefjord 2
Santa Clara 2
Zhengzhou 2
Albiate 1
Amsterdam 1
Auburn Hills 1
Augusta 1
Baghdad 1
Beaverton 1
Bratislava 1
Drancy 1
Exton 1
Florence 1
Frankfurt am Main 1
Guangzhou 1
Haikou 1
Jinan 1
Kunming 1
Lanzhou 1
Las Vegas 1
Leawood 1
Leipzig 1
Los Angeles 1
Monmouth Junction 1
Montreal 1
Prague 1
Pune 1
Redmond 1
Redwood City 1
Rome 1
Shanghai 1
Sydney 1
Taizhou 1
Trebaseleghe 1
Wuxi 1
Totale 542
Nome #
Sputum analysis: non-invasive early lung cancer detection 78
Evaluation of EZH2 expression in hepatitis B patients 64
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 64
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 64
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 63
Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. 51
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 50
SFK Inhibitors as New Strategy for RMS Treatment 49
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 48
A new parameter of growth inhibition for cell proliferation assays 43
Role of Enhancer of Zeste Homolog 2 Polycomb Protein and Its Significance in Tumor Progression and Cell Differentiation 39
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma 39
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis 36
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. 35
A Novel Role of Cdk9/CyclinT2 complexes in skeletal muscle and Rhabdomyosarcoma cells 33
BET-inhibitor I-BET762 and PARP-inhibitor talazoparib synergy in small cell lung cancer cells 28
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment 24
Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 22
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis 21
Role of enhancer of zeste homolog 2 polycomb protein and its significance in tumor progression and cell differentiation 17
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 3
Totale 871
Categoria #
all - tutte 5.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 13 12 20 2 15 5 14 0
2020/202196 13 1 13 1 14 0 14 3 15 14 6 2
2021/2022105 5 2 0 5 1 4 1 8 5 11 13 50
2022/2023287 22 43 9 52 17 51 4 23 52 0 11 3
2023/202492 20 5 1 1 9 35 0 6 0 0 11 4
2024/202573 6 4 28 26 9 0 0 0 0 0 0 0
Totale 871